Finnrick - Ensuring a Safer and More Transparent Supply Chain
Oasis Peptides

Oasis Peptides
Semaglutide

Finnrick tested 4 samples of Semaglutide (GLP-1 antagonist) from Oasis Peptides between 14 Jan 2025 and 13 Feb 2025. Test scores average below 4 or some scores below 3, and at least 2 tests, warrant a tentative Finnrick Rating of E (Bad).

Finnrick Rating™
E
BAD
Oasis Peptides
Semaglutide
Tested 4 Samples
Last test 13 Feb 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Semaglutide tests from top-rated vendors:

All Semaglutide tests from Oasis Peptides

Samples are tested in commercial labs

Tests Count

4

Scores

AVG4.4MIN2.9MAX5.3

Last

13 Feb 2025

First

14 Jan 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
13 Feb 2025View5.15mg5.943mg+18.9%99.06%(no batch ID)Grey Label / Silver Crimp / Grey CapLab CFinnrick
13 Feb 2025View5.35mg5.875mg+17.5%99.03%(no batch ID)Grey Label / Silver Crimp / Grey CapLab CFinnrick
23 Jan 2025View4.35mg5.350mg+7.0%93.35%(no batch ID)Green Label / Silver Crimp / Grey CapLab BFinnrick
14 Jan 2025View2.95mg5.638mg+12.8%96.65%(no batch ID)Green Label / Silver Crimp / Grey CapLab AFinnrick